These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16583669)

  • 1. Stage at diagnosis and first course of treatment for prostate cancer in Rhode Island, 1990-2003.
    Chiaverini LC; Fulton JP; Buechner JS
    Med Health R I; 2006 Feb; 89(2):81-2. PubMed ID: 16583669
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress in the control of prostate cancer in Rhode Island, 1987-2000.
    Chiaverini L; Fulton JP; Darcy DM
    Med Health R I; 2002 Sep; 85(9):291-3. PubMed ID: 12371217
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate cancer in Rhode Island.
    Fulton JP
    R I Med; 1995 Nov; 78(11):328-9. PubMed ID: 8547726
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for prostate cancer in Rhode Island during National Prostate Cancer Awareness Week.
    Cohen SI; Kingston T
    R I Med; 1992 Nov; 75(11):523-5. PubMed ID: 1490020
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence of increased prostate cancer screening in Rhode Island.
    Fulton JP
    Med Health R I; 2006 Aug; 89(8):288-90. PubMed ID: 16967662
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate cancer screening practice and knowledge in Rhode Island.
    Glicksman AS; Meyer A; Cullinen K
    Med Health R I; 2009 Feb; 92(2):65-6. PubMed ID: 19288690
    [No Abstract]   [Full Text] [Related]  

  • 7. Staging for prostate cancer: time to incorporate pretreatment prostate-specific antigen and Gleason score?
    Roach M; Weinberg V; Sandler H; Thompson I
    Cancer; 2007 Jan; 109(2):213-20. PubMed ID: 17167758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
    Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
    Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiologic data of uro-oncologic pathology in a urology service of a university general hospital. Comments regarding cancer of the prostate].
    Gelabert Mas A; Arango Toro O; Casamitjana Abella M; Galcerán JC; Griño Garreta J; Bielsa Galí O; Cortadellas Angel R; Nohales Taurines G; Herrero Polo M; Carrasco Cánovas N
    Actas Urol Esp; 1997 Oct; 21(9):862-7. PubMed ID: 9471869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
    Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
    Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiology of prostate cancer from three centers and analysis of the first-line hormonal therapy for the advanced disease].
    Ma CG; Ye DW; Li CL; Zhou FJ; Yao XD; Zhang SL; Dai B; Zhang HL; Zhu Y; Shen YJ
    Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):921-5. PubMed ID: 19035151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current methods of radical treatment for localized prostate cancer].
    Kaprin AD; Khmelevskiĭ EV; Fadeev AV
    Vopr Onkol; 2008; 54(1):108-12. PubMed ID: 18416071
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostate cancer: a chronic illness.
    Doyle-Lindrud S
    Clin J Oncol Nurs; 2007 Dec; 11(6):857-61. PubMed ID: 18063544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bayesian hierarchical modeling approach for studying the factors affecting the stage at diagnosis of prostate cancer.
    Zhou H; Lawson AB; Hebert JR; Slate EH; Hill EG
    Stat Med; 2008 Apr; 27(9):1468-89. PubMed ID: 17708511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in the control of prostate cancer, Rhode Island, 1987-1998.
    Fulton JP
    Med Health R I; 2001 Mar; 84(3):100-1. PubMed ID: 11280130
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in case mix and treatment patterns in prostate cancer in Saskatchewan during the prostate specific antigen testing era.
    Tonita JM; Skarsgard D; Muhajarine N
    Cancer Causes Control; 2009 Mar; 20(2):201-9. PubMed ID: 18825504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cancer of the prostate. Epidemiology, diagnosis, course and prognosis, principles of treatment].
    Le Bourgeois JP
    Rev Prat; 1989 Apr; 39(12):1077-80. PubMed ID: 2740776
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate cancer: screening, diagnosis and management in 2007.
    Grubb RL; Kibel AS
    Mo Med; 2007; 104(5):408-13; quiz 413-4. PubMed ID: 18018527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Explaining the race difference in prostate cancer stage at diagnosis.
    Jones BA; Liu WL; Araujo AB; Kasl SV; Silvera SN; Soler-Vilá H; Curnen MG; Dubrow R
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2825-34. PubMed ID: 18829446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of prostate cancer in end-stage renal disease patients.
    Kamata T; Fushimi K
    Urol Int; 2008; 80(4):419-24. PubMed ID: 18587254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.